CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 166 enrolled
Drug / intervention
Oxybutynin chloride, extended-release, individually-titrated +1 moredrug
Likely dose
Oxybutynin chloride extended-release, individually-titrated dosingAI-extracted
Key inclusion· 6
  • Ambulatory, community-dwelling women able to attend clinic visits
  • Report urge incontinence occurring at least twice per week on average
  • Incontinence persisting for at least three months
  • At least two urge accidents on 7-day baseline bladder diary, with urge accidents exceeding other types
Key exclusion· 14
  • Continual (constant) leakage
  • Active urinary tract infection (>10,000 CFU/mL on urine culture)
  • Fecal impaction
  • Uncontrolled metabolic problem

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00223821
NCT00223821N/ACompleted

Enhancing Conservative Treatment for Urge Incontinence

US Department of Veterans Affairs·interventional·Posted Sep 22, 2005·Updated Dec 19, 2013

In Brief

A clinical study evaluating Oxybutynin chloride, extended-release, individually-titrated and Behavior Training for Urinary Incontinence. Completed, enrolled 166 participants across 1 site.

Detailed Summary

The primary objective of this project is to evaluate whether enhancing drug therapy with components of behavioral training, including pelvic floor muscle rehabilitation, results in better outcomes than drug therapy alone for urge incontinence in community-dwelling women.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 22, 2005
Enrollment StartSep 1, 2003
Primary CompletionNov 1, 2008
Study CompletionDec 1, 2009
TodayJul 2, 2026
Enrollment to primary: 5.2 yearsPosted 20.8 years ago

Interventions

Oxybutynin chloride, extended-release, individually-titrateddrug

Individually-titrated, extended-release oxybutynin chloride with management of side-effects.

Behavior Trainingbehavioral

Behavioral training consists of teaching urge suppression strategies and pelvic floor muscle training.